Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3 instead of Revision: v3.5.2. This reflects a minor update to the page's content or presentation.
    Difference
    0.0%
    Check dated 2026-04-30T16:10:50.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The site version was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T11:13:16.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0. Deleted Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:52:28.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3 (from v3.4.2).
    Difference
    0.0%
    Check dated 2026-03-11T14:55:03.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page adds a reference to Primary peritoneal carcinoma and a Genetic and Rare Diseases Information Center resource, and removes the government funding notice. A revision note (v3.4.2) is also shown.
    Difference
    0.2%
    Check dated 2026-02-11T02:20:40.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A site-wide notice about funding-related delays was added, and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T00:31:24.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.